There is no market for new antibiotics: this allows an open approach to research and development.
Authors
Klug, Dana MIdiris, Fahima I M
Blaskovich, Mark A T
von Delft, Frank
Dowson, Christopher G
Kirchhelle, Claas
Roberts, Adam P
Singer, Andrew C
Todd, Matthew H
Issue Date
2021-06-11Keywords
AMRANTIBIOTICS
drug development
drug discovery
Economics
incentives
open science
policy
Metadata
Show full item recordJournal
Wellcome open researchDOI
10.12688/wellcomeopenres.16847.1PubMed ID
34250265Item Type
ArticleLanguage
enISSN
2398-502Xae974a485f413a2113503eed53cd6c53
10.12688/wellcomeopenres.16847.1